Browsing: trials

A new mRNA COVID-19 vaccine, ChulaCov19, developed in Thailand, has shown promise in Phase I trials for its durability and ability to be stored at fridge temperatures for up to three months. The development of a potentially more effective and locally-grown vaccine could have significant implications for vaccine distribution in low- and middle-income countries in the region, where storage and transport can be challenging.